These operational arguments might bring the long-standing theory into practice, starting with the initial argument of the lack of degradation in human gastric juice for periods of time longer than 24 h (for review see, [1,3,4,5,6,9,32,33,34,92]), and thereby its therapeutic effectiveness (including via a therapeutic per-oral regimen) and pleiotropic beneficial effect (for review see, i.e., [1,3,4,5,6,9,32,33,34,92])
BPC-157 and TB500 are not approved by the Therapeutic Goods Administration (TGA) and are prohibited by the World Anti-Doping Agency (WADA)
In one single-center trial of 72 subjects using a controlled-adverse-environment model, the T4 eye drop did not meet its co-primary endpoints (ocular discomfort and inferior corneal staining) at the primary time point, but it did produce statistically significant improvements on several secondary endpoints, including central and superior corneal staining, with no adverse events reported
Ferrostatin-1 reduces the inflammatory response of rheumatoid arthritis by decreasing the antigen presenting function of fibroblast-like synoviocytes
